Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 55 references it cites were found in a registry or an index; 1 of the 3 sources its claims cite were checked for support.

Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience

Open access

Abstract

Background and Objectives: Drug-related bradyarrhythmia is a well-documented major adverse event among beta-blocker users and a potential cause for hospitalization or additional interventions. Whether beta-blocker use is associated with specific bradyarrhythmia presentations, and how this relates to other predisposing factors, is not well known. We aim to evaluate the association between beta-blocker use and the type of atrioventricular (AV) conduction disorder in patients with symptomatic bradycardia. Materials and Methods: We conducted a retrospective cohort study on 596 patients with a primary diagnosis of symptomatic bradyarrhythmia admitted to a single tertiary referral center. Of the cases analyzed, 253 patients were on beta-blocker treatment at presentation and 343 had no bradycardic treatment. We analyzed demographics, clinical and paraclinical parameters in relation to the identified AV conduction disorder. A multivariate regression analysis was performed to explore factors associated with beta-blocker use. Results: Of the 596 patients (mean age 73.9 ± 8.8 years, 49.2% male), 261 (43.8%) had a third-degree AV block, 92 (15.4%) had a second-degree AV block, 128 (21.5%) had slow atrial fibrillation, 93 (15.6%) had sick sinus syndrome and 21 (3.5%) had sinus bradycardia/sinus pauses. Beta-blocker use was associated with the female gender (p < 0.001), emergency admission (p < 0.001), dilated cardiomyopathy (p = 0.003), the lower left ventricular ejection fraction (p = 0.02), mitral stenosis (p = 0.009), chronic kidney disease (p = 0.02), higher potassium levels (p = 0.04) and QRS duration > 120 ms (p = 0.02). Slow atrial fibrillation (OR = 4.2, p < 0.001), sick sinus syndrome (OR = 2.8, p = 0.001) and sinus bradycardia/pauses (OR = 32.9, p < 0.001) were more likely to be associated with beta-blocker use compared to the most common presentation (third-degree AV block), after adjusting for other patient characteristics. Conclusions: Beta-blocker use is more likely to be associated with slow atrial fibrillation, sick sinus syndrome and sinus bradycardia/pauses, compared to a second- or third-degree AV block, after adjusting for other patient factors such as gender, admission type, ECG, comorbidities, cardiac function and lab testing.

Overview

CoChat Summary

TL;DR

This retrospective single-center cohort study of 596 patients with symptomatic bradyarrhythmia found that beta-blocker use was more strongly associated with slow atrial fibrillation, sick sinus syndrome, and sinus bradycardia/sinus pauses than with second- or third-degree AV block. The authors argue this pattern may help distinguish potentially reversible drug-related bradyarrhythmia from conduction disease more likely to require pacing.

Key findings

  • Among 596 patients (mean age 73.9 ± 8.8 years; 49.2% male), 253 were on beta-blockers and 343 were not on bradycardic medication.
  • Beta-blocker use was associated with slow atrial fibrillation (OR = 4.2, p < 0.0001), sick sinus syndrome (OR = 2.8, p = 0.001), and sinus bradycardia/sinus pauses (OR = 32.9, p < 0.0001), compared with third-degree AV block.
  • Second-degree AV block was not associated with beta-blocker use (OR = 0.84, p = 0.56).
  • In adjusted analyses, beta-blocker use was also associated with female sex (p < 0.0001), emergency admission (p < 0.0001), dilated cardiomyopathy (p = 0.003), lower LVEF (p = 0.02), mitral stenosis (p = 0.009), chronic kidney disease (p = 0.02), higher potassium (p = 0.04), and QRS duration > 120 ms (p = 0.02).

Methods

  • Retrospective cohort study at a single tertiary referral center in Northeast Romania, covering admissions from December 2014 to January 2017.
  • Included 596 hospitalized adults with symptomatic bradyarrhythmia/symptomatic AV conduction disorders; excluded patients <18 years, acute coronary syndrome-related conduction disorders, non-beta-blocker bradycardic treatment, recent cardiovascular surgery or interventional procedures, pacing devices, or incomplete key data.
  • Compared BB+ (n = 253) versus BB− (n = 343) groups using t-tests/Fisher exact tests and multivariable logistic regression with backward stepwise selection.

Limitations

  • The paper states limitations of the retrospective design, the number of cases analyzed, and the specificity of the center.
  • It also states that some hospital-record data were incomplete and that type/dose of beta-blocker were susceptible to recall bias.
  • Evident from the text: this is a single-center study in one region, so generalizability is limited; the authors also note underrepresentation of some beta-blockers used less often in their region.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/medicina58020320

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

1 Valid · 0 Not valid · 0 Not checked · 34 Own results and interpretations

26 more claims

Create a free account to see all 35 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 2
  • It may state two separate claims as one. 3

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 55 references

Cited by

See all 6

Metadata

Authors
Marcu, D. T. M., Adam, C. A., Dorobanțu, D.-M., Șalaru, D. L., Sascău, R. A., Balasanian, M. O., Macovei, L., Arsenescu-Georgescu, C., & Stătescu, C.
Affiliations
  • Grigore T. Popa University of Medicine and Pharmacy (RO)
  • Institute of Cardiovascular Diseases “Prof. Dr. George I. M. Georgescu” Iași, 700115 Iași, Romania
  • Children’s Health and Exercise Research Centre (CHERC), University of Exeter, Exeter EX1 2LU, UK
  • Department of Internal Medicine, University of Medicine and Pharmacy “Grigore T. Popa” Iași, 700115 Iași, Romania
Corresponding author
Adam, Cristina Andreea
Venue
Medicina
Publisher
MDPI AG
Published
2022-02-20
Volume
58
Issue
2
Pages
320
ISSN
  • 1010-660X (ISSN-L)
  • 1648-9144
OpenAlex
W4214725880
Cited by
6
References
55
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 2
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Medicina (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • UK Research and Innovation (MR/N0137941/1)
  • Medical Research Council (MR/N0137941/1)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
beta-blockers, atrioventricular conduction disorders, symptomatic bradycardia, complete heart block, second-degree AV block, sick sinus syndrome, sinus bradycardia, risk factors, dilated cardiomyopathy, mitral stenosis, chronic kidney disease, potassium, QRS duration
MeSH terms
Aged, Aged, 80 and over, Electrocardiography, Female, Humans, Male, Retrospective Studies, Sick Sinus Syndrome, Stroke Volume, Ventricular Function, Left, Tertiary Care Centers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience. https://app.cochat.ai/papers/10.3390/medicina58020320
The paper
Marcu, D. T. M., Adam, C. A., Dorobanțu, D.-M., Șalaru, D. L., Sascău, R. A., Balasanian, M. O., Macovei, L., Arsenescu-Georgescu, C., & Stătescu, C. (2022). Beta-Blocker-Related Atrioventricular Conduction Disorders—A Single Tertiary Referral Center Experience. Medicina. https://doi.org/10.3390/medicina58020320

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.